Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Fesoterodine fumarate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fesoterodine 4mg modified-release tablets
0704020ADAAAAAA
|
Fesoterodine fumarate | Fesoterodine fumarate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 29,553 |
|
Fesoterodine 8mg modified-release tablets
0704020ADAAABAB
|
Fesoterodine fumarate | Fesoterodine fumarate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 25,719 |
|
Toviaz 4mg modified-release tablets
0704020ADBBAAAA
|
Toviaz | Fesoterodine fumarate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,047 |
|
Toviaz 8mg modified-release tablets
0704020ADBBABAB
|
Toviaz | Fesoterodine fumarate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,745 |
|
Teraleve 8mg modified-release tablets
0704020ADBDABAB
|
Teraleve | Fesoterodine fumarate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 27 |
|
Zecatrin 8mg modified-release tablets
0704020ADBCABAB
|
Zecatrin | Fesoterodine fumarate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 7 |
|
Teraleve 4mg modified-release tablets
0704020ADBDAAAA
|
Teraleve | Fesoterodine fumarate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 5 |
|
Zecatrin 4mg modified-release tablets
0704020ADBCAAAA
|
Zecatrin | Fesoterodine fumarate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.